To further muddy the waters of the intertwining relation between TET enzymes and ascorbate in myeloid disorders, a reduced TET2 activity may also result from mutations in IDH1, IDH2 and WT1, frequently reported in AML (Figure 4). Here, TET2 is linked to acute myeloid leukemia.